Active Clinical Trials

Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients

By April 24, 2017No Comments


Malignant Pleural Mesothelioma

Estimated Enrollment: 150

Age Group: Child, Adult, Senior

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Case-Only|Time Perspective: Retrospective

Study ID Numbers: ONC/OSS-02/2012

Study First Received: May 27, 2013

Last Updated: February 9, 2017

Estimated Primary Completion Date: December 2016


Primary Outcome Measures:

Expression of TUBB3 and BRCA1 in MPM tumor tissue by immunohistochemistry and RT-PCR.|Association of expression of TUBB3 and BRCA1 with clinical outcome (response, survival) .

Sponsors and Collaborators:

Armando Santoro, MD|Istituto Clinico Humanitas

Website Link:

Leave a Reply

Call Now ButtonCall Now